ELFN1-AS1 Promotes GDF15-mediated Immune Escape of Colorectal Cancer from NK Cells by Facilitating GCN5 and SND1 Association

Overview

Journal Discov Oncol

Publisher Springer

Specialty Oncology

Date 2023 May 5

PMID 37147528

Authors

Bin Han

Jinsong He

Qing Chen

Min Yuan

Xi Zeng

Yuanting Li

Yan Zeng

Meibo He

Qilin Zhou

Dan Feng

Daiyuan Ma

Affiliations

Soon will be listed here.

Abstract

The ability of colorectal cancer (CRC) cells to escape from natural killer (NK) cell immune surveillance leads to anti-tumor treatment failure. The long non-coding RNA (lncRNA) ELFN1-AS1 is aberrantly expressed in multiple tumors suggesting a role as an oncogene in cancer development. However, whether ELFN1-AS1 regulates immune surveillance in CRC is unclear. Here, we determined that ELFN1-AS1 enhanced the ability of CRC cells to escape from NK cell surveillance in vitro and in vivo. In addition, we confirmed that ELFN1-AS1 in CRC cells attenuated the activity of NK cell by down-regulating NKG2D and GZMB via the GDF15/JNK pathway. Furthermore, mechanistic investigations demonstrated that ELFN1-AS1 enhanced the interaction between the GCN5 and SND1 protein and this influenced H3k9ac enrichment at the GDF15 promotor to stimulate GDF15 production in CRC cells. Taken together, our findings indicate that ELFN1-AS1 in CRC cells suppresses NK cell cytotoxicity and ELFN1-AS1 is a potential therapeutic target for CRC.

Citing Articles

Increased Growth Differentiation Factor 15 Levels Are Associated with HIV-Associated Neurocognitive Impairment: A Pilot Study.

Boustani A, Ford M, Kulbe J, Laird A, Shu L, Spencer M Brain Sci. 2025; 15(1).

PMID: 39851417 PMC: 11763450. DOI: 10.3390/brainsci15010049.

Identification of a Novel 4-gene Prognostic Model Related to Neutrophil Extracellular Traps for Colorectal Cancer.

Qian J, Duan J, Cao D Turk J Gastroenterol. 2024; 35(11):849-858.

PMID: 39549020 PMC: 11562497. DOI: 10.5152/tjg.2024.24131.

Identification of a novel cellular senescence-related lncRNA signature for prognosis and immune response in osteosarcoma.

Wu H, Deng C, Zheng X, Huang Y, Chen C, Gu H Transl Cancer Res. 2024; 13(7):3742-3759.

PMID: 39145087 PMC: 11319968. DOI: 10.21037/tcr-24-163.

Involvement of tumor immune microenvironment metabolic reprogramming in colorectal cancer progression, immune escape, and response to immunotherapy.

Nicolini A, Ferrari P Front Immunol. 2024; 15:1353787.

PMID: 39119332 PMC: 11306065. DOI: 10.3389/fimmu.2024.1353787.

The functions and mechanisms of long non-coding RNA in colorectal cancer.

Lin Y, Zhao W, Lv Z, Xie H, Li Y, Zhang Z Front Oncol. 2024; 14:1419972.

PMID: 39026978 PMC: 11254705. DOI: 10.3389/fonc.2024.1419972.

References

Lu X, He X, Su J, Wang J, Liu X, Xu K . EZH2-Mediated Epigenetic Suppression of GDF15 Predicts a Poor Prognosis and Regulates Cell Proliferation in Non-Small-Cell Lung Cancer. Mol Ther Nucleic Acids. 2018; 12:309-318. PMC: 6031151. DOI: 10.1016/j.omtn.2018.05.016. View

Fionda C, Scarno G, Stabile H, Molfetta R, Di Censo C, Gismondi A . NK Cells and Other Cytotoxic Innate Lymphocytes in Colorectal Cancer Progression and Metastasis. Int J Mol Sci. 2022; 23(14). PMC: 9322916. DOI: 10.3390/ijms23147859. View

Li S, Ma Y, Zheng P, Zhang P . GDF15 promotes the proliferation of cervical cancer cells by phosphorylating AKT1 and Erk1/2 through the receptor ErbB2. J Exp Clin Cancer Res. 2018; 37(1):80. PMC: 5894198. DOI: 10.1186/s13046-018-0744-0. View

Kim T, Jeon Y, Cui R, Lee J, Peng Y, Kim S . Role of MYC-regulated long noncoding RNAs in cell cycle regulation and tumorigenesis. J Natl Cancer Inst. 2015; 107(4). PMC: 4402359. DOI: 10.1093/jnci/dju505. View

Song H, Park H, Kim J, Park G, Kim Y, Kim S . IDO metabolite produced by EBV-transformed B cells inhibits surface expression of NKG2D in NK cells via the c-Jun N-terminal kinase (JNK) pathway. Immunol Lett. 2011; 136(2):187-93. DOI: 10.1016/j.imlet.2011.01.009. View

Xu F, Hua Q, Zhang A, Di Z, Wang Y, Zhao L . LncRNA AC020978 facilitates non-small cell lung cancer progression by interacting with malate dehydrogenase 2 and activating the AKT pathway. Cancer Sci. 2021; 112(11):4501-4514. PMC: 8586664. DOI: 10.1111/cas.15116. View

Cao C, Li J, Li G, Hu G, Deng Z, Huang B . Long Non-coding RNA TMEM220-AS1 Suppressed Hepatocellular Carcinoma by Regulating the miR-484/MAGI1 Axis as a Competing Endogenous RNA. Front Cell Dev Biol. 2021; 9:681529. PMC: 8376477. DOI: 10.3389/fcell.2021.681529. View

Chaudhry K, Dowlati E, Long M, Geiger A, Lang H, Gomez E . Comparable transforming growth factor beta-mediated immune suppression in ex vivo-expanded natural killer cells from cord blood and peripheral blood: implications for adoptive immunotherapy. Cytotherapy. 2022; 24(8):802-817. PMC: 10258734. DOI: 10.1016/j.jcyt.2022.04.001. View

Jandura A, Krause H . The New RNA World: Growing Evidence for Long Noncoding RNA Functionality. Trends Genet. 2017; 33(10):665-676. DOI: 10.1016/j.tig.2017.08.002. View

10.

Zhang K, Zhu W, Wang S, Gao C, Pan J, Du Z . Organ-specific cholesterol metabolic aberration fuels liver metastasis of colorectal cancer. Theranostics. 2021; 11(13):6560-6572. PMC: 8120208. DOI: 10.7150/thno.55609. View

11.

Fu X, Zhang C, Meng H, Zhang K, Shi L, Cao C . Oncoprotein Tudor-SN is a key determinant providing survival advantage under DNA damaging stress. Cell Death Differ. 2018; 25(9):1625-1637. PMC: 6143532. DOI: 10.1038/s41418-018-0068-9. View

12.

Kumar D, Hosse J, von Toerne C, Noessner E, Nelson P . JNK MAPK pathway regulates constitutive transcription of CCL5 by human NK cells through SP1. J Immunol. 2009; 182(2):1011-20. DOI: 10.4049/jimmunol.182.2.1011. View

13.

Fang P, Xiang L, Chen W, Li S, Huang S, Li J . LncRNA GAS5 enhanced the killing effect of NK cell on liver cancer through regulating miR-544/RUNX3. Innate Immun. 2019; 25(2):99-109. PMC: 6830859. DOI: 10.1177/1753425919827632. View

14.

Li C, Hong S, Hu H, Liu T, Yan G, Sun D . MYC-Induced Upregulation of Lncrna ELFN1-AS1 Contributes to Tumor Growth in Colorectal Cancer via Epigenetically Silencing TPM1. Mol Cancer Res. 2022; 20(11):1697-1708. DOI: 10.1158/1541-7786.MCR-22-0009. View

15.

Zhou J, Valentini E, Boutros M . Microenvironmental innate immune signaling and cell mechanical responses promote tumor growth. Dev Cell. 2021; 56(13):1884-1899.e5. DOI: 10.1016/j.devcel.2021.06.007. View

16.

Luo K, Song Y, Guan Z, Ou S, Ye J, Ran S . A KRAS-Associated Signature for Prognostic, Immune and Chemical Anti-Cancer Drug-Response Prediction in Colon Cancer. Front Pharmacol. 2022; 13:899725. PMC: 9237412. DOI: 10.3389/fphar.2022.899725. View

17.

Ho C, Donovan-Banfield I, Tan L, Zhang T, Gray N, Strang B . Inhibition of IKKα by BAY61-3606 Reveals IKKα-Dependent Histone H3 Phosphorylation in Human Cytomegalovirus Infected Cells. PLoS One. 2016; 11(3):e0150339. PMC: 4773098. DOI: 10.1371/journal.pone.0150339. View

18.

Tabarsa M, You S, Yelithao K, Palanisamy S, Prabhu N, Nan M . Isolation, structural elucidation and immuno-stimulatory properties of polysaccharides from Cuminum cyminum. Carbohydr Polym. 2020; 230:115636. DOI: 10.1016/j.carbpol.2019.115636. View

19.

Lei R, Feng L, Hong D . ELFN1-AS1 accelerates the proliferation and migration of colorectal cancer via regulation of miR-4644/TRIM44 axis. Cancer Biomark. 2020; 27(4):433-443. DOI: 10.3233/CBM-190559. View

20.

Roth P, Junker M, Tritschler I, Mittelbronn M, Dombrowski Y, Breit S . GDF-15 contributes to proliferation and immune escape of malignant gliomas. Clin Cancer Res. 2010; 16(15):3851-9. DOI: 10.1158/1078-0432.CCR-10-0705. View